These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8977230)

  • 1. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18.
    Barna BP; Dweik RA; Farver CF; Culver D; Yen-Lieberman B; Thomassen MJ
    Clin Immunol; 2002 May; 103(2):169-75. PubMed ID: 12027422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon gamma and tumor necrosis factor alpha production in bronchoalveolar leukocytes from patients with small cell lung cancer.
    Cembrzyńska-Nowak M; Bieńkowska M; Szklarz E
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):367-74. PubMed ID: 9883316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics and stimulant dependence of cytokine production by blood and bronchoalveolar lavage T cells evaluated at the single cell level.
    Madden J; Howarth PP; Godfrey RR; Frew AA
    Cytokine; 1999 Jul; 11(7):510-7. PubMed ID: 10419652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
    J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
    Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
    J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice.
    Karpuzoglu-Sahin E; Zhi-Jun Y; Lengi A; Sriranganathan N; Ansar Ahmed S
    Cytokine; 2001 May; 14(4):208-17. PubMed ID: 11448120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
    Huang H; Meyer KC; Kubai L; Auerbach R
    Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of IFN-gamma mRNA stability by IL-12/NKSF.
    Nagy E; Buhlmann JE; Henics T; Waugh M; Rigby WF
    Cell Immunol; 1994 Dec; 159(2):140-51. PubMed ID: 7994750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
    Kohno K; Kataoka J; Ohtsuki T; Suemoto Y; Okamoto I; Usui M; Ikeda M; Kurimoto M
    J Immunol; 1997 Feb; 158(4):1541-50. PubMed ID: 9029088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
    Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
    Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.